Clinical Chemistry

Article	Citations
Commentary on A Differential Diagnosis of Thrombotic Microangiopathy in a 7-Year-Old Girl	142
Persistently Positive Urine Amphetamines Confirmation Testing	93
Commentary on Understanding Elevated Vitamin D Measurements to Uncover Hypercalcemia Etiology	88
Are Anti-Receptor–Binding Domain Antibodies Still a Relevant Proxy for Monitoring SARS-CoV-2 Neutralizing Activity in the Omicron Era?	82
Correction to: Driving Under the Influence of Cannabis: Impact of Combining Toxicology Testing with Field Sobriety Tests	70
Low Free T4 in a 13-Year-Old Girl with Short Stature and Blurry Vision	70
Clinical Chemistry's Invited Reviewers 2024	63
A-154 Reduction in Turnaround Time Achieved by Simplifying Hematology Middleware Rules	60
Cardiac Troponin I or T for the Diagnosis of Myocardial Infarction and Prediction of Outcomes—Does It Matter?	60
A-170 CBC Results, flags and scattergram using BC 6800Plus Hematology Analyzer, for a case of Burkitt*s lymphoma in leukemic phase	59
A-213 Highlights on Daily Internal Quality Controls for Improved Analytical Performance in Clinical Laboratory	58
A-268 Evaluation of NAAT Recovery of Highly Pathogenic Avian Influenza A (H5N1) Clade 2.3.4.4b from Novel Proficiency Samples	56
A-032 Evaluation of the Analytical Performance of Total Triiodothyronine (T3) and Total Thyroxine (T4) Assays on the Atellica CI Analyzer	53
A-291 Rapidly Ruling Out Bacterial Infection: A Novel Host-Protein Assay for Patients with Suspected Respiratory Tract Infections in the Emergency Department	52
A-172 Graphical contribution and CBC of BC-6800Plus hematology analyzer in a case of Myelodisplastic Syndrome related to Chemotherapy and Radiotherapy	51
A-181 Stability of urine in the BD Vacutainer® Plus Conical Urinalysis Preservative Tubes for Chemical and Microscopic Urinalysis	48
B-043 Clinical performance evaluation of the ABD PAD® as confirmatory testing of blood group	45
A-312 Evaluation of the Analytical Performance of the Hepatitis B Surface Antigen and confirmatory assays on the Atellica CI Analyzer	45
B-007 Activin A is a potential mediator of TGFß1-induced tubulointerstitial fibrosis	37
B-088 Stability Assessment of Hormones and Tumor Markers: Can We Ensure High-Quality Patient Results Despite Operational Challenges?	36
B-277 Validation of an Enzymatic Method for Quantification of Ethylene Glycol in Human Serum	35
B-214 Migration of a Previously Validated Sequencing Workflow of 4,700 Genes Associated with Clinical Phenotypes to the MGI DNBSEQ-G400 Platform: High-Quality NGS Data with Elevated Concordance to Exp	35
A-050 The Role of Gut Microbial Metabolite Trimethylamine N-Oxide in Adrenal Cholesterol Homeostasis	33
B-117 Inverse Association Between Regulatory T and B Cells with HLA antibodies and Donor-specific Antibodies in Kidney Transplantation	33
A-034 Prevention of Obesity and Metabolic Disorders Through a Gut Microbial Metabolite Derived from Polyphenol Supplementation in a High-Fat Diet	33

B-278 Xylazine Detection in Clinical Urine Specimens Ordered for Comprehensive Drug Screening	33
A-072 The Impact of Short and Prolonged Fasting on Routine Lab Tests	33
B-182 Evaluating Clinical Biochemical Diagnostic Approaches for Mitochondrial Diseases	33
A-125 Difference Between the Results of Vitros® Dry Biochemistry and Wet Biochemistry with Kinetic Method in Diagnosing the Comorbidity of Lung Adenocarcinoma and Aacroamylasemia: Case Report	32
B-314 Utility of he4 in differential diagnosis of pleural effusions	32
A-194 Intravenous Fluid Contamination of Basic Metabolic Panels Is Underrecognized by Manual Workflows	32
B-048 Proposal of a new monitoring algorythm for patients with a HIV positive result with the Elecsys HIV DUO test	31
A-249 Theranostic Algorithm: sensitivity and Specificity of a Composite Index Test for Guiding Treatment in Severe COVID-19	31
A-390 Implementation of the New GEM Hemochron 100 Point-of-care Coagulation System for Heparin Monitoring During Cardiopulmonary Bypass Procedures	30
B-080 Analytical Performance of ESPLINE HTLV-I/II	30
B-276 Preservation of Proteomic Inflammatory Biomarkers signal in a Saliva Multiomic Buffer at Room Temperature	29
B-102 The Impact of Protein / Protein Interactions on Serum Free Light Chain Assay Calibration	29
B-090 Evaluation of Clinical Serology Assays Through the Development of Linearity Materials for aHBs IgG, Rubella IgG, and Toxoplasma IgG	28
B-097 Storage Stability of HbA1c in Whole Blood Tubes at Room Temperature on the Abbott Alinity c Clinical Chemistry System	27
B-305 A Novel Dilute-n-shoot Method for Quantitating Isotonitazene and Desmetonitazene in Human Urine By LC/MS	27
B-255 Engineered Reverse Transcriptases and Taq DNA Polymerases Deliver Robust Yield in the Presence of Clinically Relevant Inhibitors	27
A-059 Validation of self-collected capillary dried blood spot collection for clinical HbA1c testing	26
A-377 The Selection and Implementation of POC Illicit Drug Toxicology Testing in Hamad Medical Corporation - Doha, Qatar	26
A-143 Comparative Evaluation of K2EDTA Performance in Multinational Vacutainers: A Case Study of “DBO” by Schraubg and “BD” by Becton, Dickinson	26
A-101 Is That Unexpected? Education on Handling Real World Complications with Tightly Controlled Analytes During Method Evaluation	26
B-247 Rapid and Field-deployable Microchip-based Real-time PCR for Hepatitis B Virus DNA Detection	26
A-173 Evaluation of Artificial Intelligence (AI)-assisted Flow Cytometry Analysis for Plasma Cell Neoplasms	26
A-023 Performance Evaluation of the Atellica IM High-Sensitivity Troponin I Assay on the Atellica CI 1900 Analyzer	25
B-253 Using biomarkers in recurrent renal stone formers to detect silent stones	25
B-208 Room Temperature Stable PCR Reagents Preparation Using Capillary-Mediated Vitrification Process	25
A-343 Novel In-Line Hemolysis Detection on a Blood Gas Analyzer for Capillary Samples	25
B-011 Analytical Validation of a New Vasoactive Intestinal Peptide Radioimmunoassay	23
B-110 Validation of Digital and Automated anti-dsDNA IFA Interpretations Using the dIFine Automated Fluorescent Microscope System	23
A-339 Utomated Flow of a Non-invasive Fetal Gender Determination Lab-developed Molecular Test	23
B-092 Effect of the Increased Specificity in a Recombinant anti-tTG Assay on a Celiac Disease Diagnostic Algorithm	23
B-067 Human IgE Monoclonal Antibodies as Unique Tools for Allergy Diagnostics	23
A-117 Performance Evaluation of five Sentinel Diagnostics’ Assays on Beckman Coulter DxC 500 AU Clinical Chemistry Analyzer	23
A-142 Comparison of Alinity c Hemoglobin A1c Immunoassay with Premier Hb9210 Automated HPLC Assay: Very Few Patients May be Outside Reportable Range Using Alinity c.	22
A-292 The Use of Third-Party Controls During Covid-19 Pandemic: An Alternative to the Lack of Other Respiratory Infections	22
Urine Cell-Free RNA vs Plasma Cell-Free RNA for Monitoring of Kidney Injury and Immune Complications	22
Expression Patterns and Corepressor Function of Retinoic Acid-induced 2 in Prostate Cancer	21
Using Both Plasma and Urine Donor-Derived Cell-Free DNA to Identify Various Renal Allograft Injuries	21
Quantitative Analysis of a Novel Metabolite Panel to Estimate GFR (Panel eGFR) in Serum and Plasma Using LC-MS/MS	21
Third-Generation Single-Molecule Sequencing for Preimplantation Genetic Testing of Aneuploidy and Segmental Imbalances	21
Evaluation of Neutralizing Antibodies against SARS-CoV-2 Variants after Infection and Vaccination Using a Multiplexed Surrogate Virus Neutralization Test	20
Cerebrospinal Fluid Homovanillic and 5-Hydroxyindoleacetic Acids in a Large Pediatric Population; Establishment of Reference Intervals and Impact of Disease and Medication	20
Comprehensive Analysis of PKD1 and PKD2 by Long-Read Sequencing in Autosomal Dominant Polycystic Kidney Disease	20
Correlations Within and Between Highly Multiplexed Proteomic Assays of Human Plasma	19
A Comprehensive Review of Estradiol, Progesterone, Luteinizing Hormone, and Follicle-Stimulating Hormone in the Context of Laboratory Medicine to Support Women's Health	19
Evolutions in Clinical Chemistry	19
Bridging the Gap: Inclusion of Pregnant Women in Clinical Drug Trials	19
Reflecting on 70 Years of Clinical Chemistry	19
Lower Limits for Reporting High-Sensitivity Cardiac Troponin Assays and Impact of Analytical Performance on Patient Misclassification	19
Abatacept as a Mimic of Gamma Heavy Chain Disease	19
New American Society of Hematology Thrombophilia Guidelines Could Provoke Surge in Laboratory Testing	19

“Fireworks” in Fatty Urine	18
A Paradigm Shift: Engagement of Clinical Chemistry and Laboratory Medicine Trainees by Innovative Teaching Methods	18
B-321 Development of Chemiluminescent Enzyme Immunoassay (CLEIA) for Detecting Methotrexate in Blood	18
A Comment about Analytical Performance Specifications for the Combined Measurement Uncertainty Budget in the Implementation of Metrological Traceability of Parathyroid Hormone	18
A “Total” Interference	18
B-214 Serial Changes of Donor-derived Cell-free DNA in Pancreas Transplant Recipients	18
B-089 Development of a Secondary Standard for Quantitation of IgG Antibodies to SARS-CoV-2 Proteins in a Multiplex Assay	18
B-302 Increased False-Positives vs Increased Interference Flags: Using the AU 5800 to Compare Two Ethyl Glucuronide Assays	18
Expanding Access to Noninvasive Prenatal Diagnosis for Monogenic Conditions to Consanguineous Families	18
Commentary on Multiple Copy Number Variants Detected by Noninvasive Prenatal Screening	18
A-114 Protective effect of leukocytes in preventing Cold Induced Hyperkalemia	18
B-186 Pericentric Inversion of Chromosome 9-inv(9)(p12q13): Findings Beyond Infertility Encountered on a Retrospective Study	18
A-119 Lipemia Interference	17
B-213 Including Turner Syndrome Screening in Newborn Sequencing by Using NGS Read Counts to Infer Sex Chromosomes Copy Number: Leveraging Existing Data to Enhance Early Diagnosis	17
B-141 Surprisingly Good Agreement of Siemens and Roche ALT Reference Change Values in Ottawa Hospital Outpatients Distilled from 5 years and 3 years of Siemens and Roche ALT, Respectively	17
B-107 Advancing Parasitology Laboratory Quality and Processes Through Artificial Intelligence (AI) and Automation	17
A-166 Performance verification of a polyclonal anti-PF4 immunoassay in evaluation of Heparin Induced Thrombocytopenia (HIT)	17
A-002 Analytical Validation of the Zybio High Sensitivity Cardiac Troponin I CLIA Assay	17
B-138 A Harmonization Program Leading to Improved Accuracy and Precision of Hemoglobin A1c (HbA1c) Testing: A Six-Year Multi-Site, Multi-Instrument Review and Comparison	17
B-230 Monitoring SARS-CoV-2 Subvariants for Evaluation of the Diagnostic Kit’s Annealing Site Using Nanopore Sequencing	17
A-167 Hematologic setpoints are a deep physiologic phenotype which enable personalized blood count reference intervals	16
B-378 Cell-free Plasma Preparation Workflow Solution	16
A-021 Evaluation of a Novel N Terminal Pro B Type Natriuretic Peptide Assay as an aid in the Diagnosis of Acute Heart Failure in the Emergency Department	16
B-329 Comparison Between Trough and AUC Monitoring of MPA in Patients With and Without Organ Transplantation. Influence of the Co-administered Immunosuppressant	15
B-242 Improved Patient Satisfaction With Novel Capillary Blood Collection Devices as an Alternative to Venipuncture for Applications in Clinical Proteomic Assays	15
B-010 Comparison of Manual Urine Dipstick and Microscopy With Automated UC-3500 and UF-4000 Sysmex UN Series Urinalysis; A Comparative Experimental Research Approach at an Urban Referral Hospital in G	15
B-086 High Precision T Cell Testing Using the T-SPOT Technology: Improved Cell Yields From Lower Volumes of Blood When the T-SPOT Technology is Used With the T-Cell Select Reagent Kit for Cell Isolati	15
A-086 Clinical Performance of a Plasma ATN Panel for Assessment of Alzheimer’s Disease	15
B-147 Evaluation of Laboratory Database: Is there a Causal Relationship between COVID-19 and Type 1 Diabetes	15
B-149 Next-generation Sequencing Via Targeted Metagenomics for Broad Antimicrobial Resistance Surveillance	15
B-071 Unraveling Histamine Intolerance: Exploring DAO Quantity, Elimination Ratios and Cofactor Influences	15
A-342 Precision Evaluation of the pH, PO2 and PCO2 tests in the i-STAT® G3+ Cartridge using the i-STAT 1 System for Venous, Arterial and Capillary Whole Blood Specimens in	15
B-266 Therapeutic Drug Monitoring of Natalizumab and Anti-Natalizumab Antibodies	14
B-301 In-vivo Continuous Therapeutic Drug Monitoring With Electrochemical Aptamer-based Sensors	14
B-214 Mutational Landscapes of Acute Myeloid Leukemia and Myelodysplastic Syndromes: A Database-Driven Comprehensive Myeloid Panel Analysis of DNA Variants and Gene Fusions	14
B-173 Cystine Analysis in Urine Sample Using the Laser Diode Thermal Desorption technique “LDTD”/Mass Spectrometry (Luxon)	14
B-222 Receptor-donor CYP3A5 and CYP3A4 genotype testing in liver transplant patients and its influence in tacrolimus blood levels: a retrospective study	14
B-015 Magnesium Fractionation using Ultrafiltration System	14
A-128 Analytical Performance Evaluation of Assays Used for Iron Studies on the Atellica® CI 1900 Analyzer	13
Deconvolution of BNP and NT-proBNP Immunoreactivities by Mass Spectrometry in Heart Failure and Sacubitril/Valsartan Treatment	13
Enrichment of Microbial DNA in Plasma to Improve Pathogen Detection in Sepsis: A Pilot Study	13
A-180 A Retrospective Review of Syphilis Serology Interpretation Accuracy	13
Commentary on A Patient with Coarse Facial Features and Molecular Odyssey: Lessons Learned and Best Practice	13
Assessing the Quality of Metagenomic Next-Generation Sequencing for Pathogen Detection in Lower Respiratory Infections	13
A-302 Agreement Assessment Between Molecular and Rapid Tests in Respiratory Viruses Detection	13
B-182 Development and validation of an LC-MS/MS assay for simultaneous measurement of serum androstenedione and 17-hydroxyprogesterone in serum	13
Establishing Pragmatic Analytical Performance Specifications for Blood Beta-Hydroxybutyrate Testing	13
A-010 Clinical Performance of an N-Terminal Pro-B-Type Natriuretic Peptide Assay in Acute Heart Failure Diagnosis	12
A-180 Counting CAP deficiency Caused by Clerical errors: a regional study	12
A-191 Evaluating the Impact of Drone Delivery on Blood Sample Quality: A Multi-faceted Validation Approach	12
A-155 HbS, HbF and HbA2 reference intervals in a sickle cell population with Senegal haplotype as the most prevalent sickle cell haplotype	12
A-080 Clinical Significance of Magnesium in Patients Undergoing Renal Dialysis	12
B-114 Analytical characterization of a host-response test able to rapidly differentiate bacterial from viral infections developed for use on Beckman Coulter immunoassay analyzers	12
Worldwide Increasing Use of Nonfasting Rather Than Fasting Lipid Profiles	12
A-133 iSED PRO: Utilizing Photometric Rheology to Modernize High Throughput Erythrocyte Sedimentation Rate Testing	12
A-227 Breaking Barriers in Laboratory Efficiency: A PDCA-Driven Approach to Fasting Emergency Testing	12
A-275 Evaluation of Dried Blood Spots for Serological Detection of Chagas Disease	12
B-193 Establishing a robust liquid chromatography-tandem mass spectrometry method for urinary steroid profiling with efficient enzymatic pretreatment	11
B-036 Paving the path for autonomous mobile robots (AMRs) in the clinical laboratory: A pilot study of Collaborative Robotics (Cobot) Proxie robot for cart movement at Mayo Clinic Laboratories	11
B-069 An Effort on Improvement of the Anti M-Protein Interference to Enzymatic Creatinine Assay on Mindray BS-2800M System	11
B-206 The Determination of Vanillylmandelic Acid (VMA), Homovanillic Acid (HVA) and 5-Hydroxyindolacetic Acid (5-HIAA) by LC-Ms/MS Assay in Urine Samples for Diagnosis of Neuroendocrynes Tumors	11
B-367 Correlation of kappa and lambda free light chain results between Siemens N Latex assays on BN II analyzer and Binding Site Freelite assays on Optilite platform	11
B-079 Analytical comparison of a novel, fully automated multiplexed microarray immunoassay and routine methods for the detection of celiac disease autoantibodies in a reference laboratory in Wales	11
B-006 Locus Coeruleus Activation Causes Dynorphin Release in Mouse Brain: Implications for Neural Inflammation	11
A-052 Clinical usefulness of ADAMS A1c HA-8190V automatic switching mode for the HbA1c measurement in Hb variants	11
Ceramide Risk Scores Can Bring Lipidomics to Clinical Medicine	11
B-062 Impact of prolonged air exposure on stability of Carbon Dioxide (CO2), Chloride (Cl), Potassium (K) and Sodium (Na) assessed by Roche Cobas® c702 Analyzer	11
B-198 Comparative Analysis of Inductively Coupled Plasma-Mass Spectrometry (ICP-MS) with Kinetic Energy Discrimination Mode Using Helium and ICP-MS/MS with Collision/Reaction Cell Mode Using Oxygen fo	11
B-293 Comparison of Therapeutic Drug Monitoring for Clozapine by Immunoassay vs. Mass-Spectrometry	11
Long-Term Within- and Between-Subject Biological Variation Data of Hematological Parameters in Recreational Endurance Athletes	11
A-038 Interlaboratory Comparison of Parathyroid Hormone Analytical Results Across Clinical Assays from 8 Manufacturers - Steps Towards Standardization	11
A Modified Sampson–NIH Equation with Improved Accuracy for Estimating Low Levels of Low-Density Lipoprotein-Cholesterol	10
UMIErrorCorrect and UMIAnalyzer: Software for Consensus Read Generation, Error Correction, and Visualization Using Unique Molecular Identifiers	10
A New Concept for Reference Change Values—Regression to the Population Mean	10
We All Know Standardization Is Key, But How Do We Get There with Clinical Metagenomics?	10
Jagged Ends on Multinucleosomal Cell-Free DNA Serve as a Biomarker for Nuclease Activity and Systemic Lupus Erythematosus	10
Low-Pass Whole Genome Sequencing of Cell-Free DNA from Cerebrospinal Fluid: A Focus on Pediatric Central Nervous System Tumors	10
Analytical Considerations in Deriving 99th Percentile Upper Reference Limits for High-Sensitivity Cardiac Troponin Assays: Educational Recommendations from the IFCC Committee on Clinical Application o	10
The Unique Utility of Newborn Dried Blood Spots for Driving Discovery in Childhood Cancer Research	10
A-073 Is there a relationship of FIB 4 with weight and insulin resistance in subjects without type 2 diabetes and with normal transaminases?	9

A-054 Comparison of a Reformulated Vitamin D Immunoassay, Its Predecessor, and Two Contemporary Formulations	9
Detection of Clinically Relevant Monogenic Copy-Number Variants by a Comprehensive Genome-Wide Microarray with Exonic Coverage	9
A-219 A Multiplexed Targeted Assay for Gangliosides Using Liquid Chromatography-Tandem Mass Spectrometry	9
B-220 Clinical Application of the “Clg-Fish” Technique for the Diagnosis of Multiple Myeloma	9
B-098 Clinical comparison of five assays for the detection of anti-dsdna antibodies and their correlation with complement consumption	9
A-228 Performance Evaluation of the LabGenius C-CT/NG-BMX Assay for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae	9
A-049 Inter-assay Variation of Insulin-like Growth Factor-1 Remains an Issue	9
A-389 Implementation of a solicited laboratory workflow improves quality indicators for point of care blood gas testing by Respiratory Therapists	9
A-233 Novel Microfluidic System for Antimicrobial Susceptibility Testing	9
Commentary on Mosaic Copy Number Variation in a Patient with Cerebral and Pulmonary Arteriovenous Malformations and Recurrent Epistaxis	9
A-346 Evaluating 14-3-3η Detection in Finger Prick Blood Using Lateral Flow Technology: Advancing Clinical Laboratory Diagnostics	9
B-308 Analytical and clinical performance of a novel ovarian cancer screening test in asymptomatic women	9
A-297 Usefulness of Non-Skin Samples in the PCR Diagnosis of Monkeypox	9
B-056 Performance Characteristics of a New, Fully Automated Planar Microarray Immunoassay for the Detection of IgG Auto-Antibodies Against Centromere Protein B (CENP-B)	9
A-009 Analytical Characterization of a Novel NT-proBNP Assay on a Central Laboratory Platform	9
Challenges in Hb A1c Point-of-Care Testing: Only 5 of 19 Hb A1c Point-of-Care Devices Meet IFCC and NGSP Certification Criteria on Independent Evaluation	9
B-054 Performance Evaluation of the VITROS HIV Combo Assay on the Ortho VITROS 3600 system	9
B-181 Multi-centre Analytical Performance Evaluation of the EXENTâ Solution for Identification and Quantitation of Monoclonal Immunoglobulins	9
A-191 Improvement of Outpatient Satisfaction Rate at Specimen Collection Area	9
A-156 White Blood Cell Measurands, Flagging and Scatter Plot Patterns in Chronic Lymphocytic Leukemia	9
B-233 Chromatin Accessibility Uncovers KRAS-driven FOSL2 Promoting Pancreatic Ductal Adenocarcinoma Progression Via Upregulating CCL28	9
Harmonization Status of Serum Ferritin Measurements and Implications for Use as Marker of Iron-Related Disorders	9
A-322 Implementation of Three Age- and Sex-Dependent Equations to Estimate Glomerular Filtration Rates (eGFR) at a Pediatric Institution	9
Commentary on An Unusual Presentation of Autoimmune Primary Adrenal Insufficiency	8
A-258 Hepatitis A infections among patients suspected of acute hepatitis attended in Brazilian health services	8
A-259 Urine Gene Analysis Compared to Urine Culture For Pathogen Detection	8
B-044 A Statistical and Rule-Based Approach to Automating Glioblastoma Detection	8
A-205 Abbott Alinity i Analyzers: More Than Just Hot Air!	8
A-353 Lay User testing of Rapid Multiplexed HIV/TP test	8
B-208 Correlation Studies of Human Papillomavirus DNA on Roche Cobas vs Human Papillomavirus mRNA on Hologic Panther	8
In Reply to Beyond the Screen Positive Rate: Racial Equity Considerations for Serum Screening for Open Neural Tube Defects	8
A-162 Prevalence of EDTA-Dependent Pseudothrombocytopenia: A 10-Year Analysis	8
B-078 Validation of the GCAL®, Gentian Calprotectin Immunoassay on the QuidelOrtho Vitros 5600 Chemistry Analyzer	8
A-198 Reducing Specimen Rejections in Ambulatory Care Clinics to Improve Patient Safety and Efficiency	8
More Than a Decade of Rapid Genomic Sequencing: Where Are We Now?	8
B-278 Pilot Clinical Study of the CarePoint Assay	8
A-056 Ex-Vivo Parathyroid Aspiration in Parathyroidectomy: Correlation with Histopathology and Biochemical Outcomes in Single- and Multi-glandular Primary Hyperparathyroidism	8
A-282 Detection of anti-Oropouche virus-specific IgM in a patient panel from a Zika virus epidemic area in 2015 / 2016	8
A-348 Pediatric reference intervals for 12 enzymes, proteins, and lipids on the Roche cobas® pro Integrated System established using the CALIPER cohort of healthy children	8
B-234 Detection of multiple targets in a single fluorescent channel: Respiratory virus multiplex RT-qPCR assay	7
B-168 Establishment of reference intervals of serum immunoglobulin and complement by Hoffmann and refineR algorithms and evaluation of their feasibility	7
A-322 ELISA-based determination of anti-mumps IgG reveals a prevalence of 80 percent in sera obtained in Brazil	7
A-299 The Clinical Triaging Impact of New HPV Platforms. A Comparison of mRNA and DNA Based Platforms	7
Patient with a New Small IgG Kappa Monoclonal Protein	7
Multiple Cardiac Biomarkers to Improve Prediction of Cardiovascular Events: Findings from the Generation Scotland Scottish Family Health Study	7
A-347 Statistical determination of infant (<6 months) PT and PTT reference intervals	7
A-211 A real-world retrospective multi-hospital database evaluation of the clinical care gaps associated with urine contamination/ false positive cultures and associated outcomes in the United States	7
A-129 ANALYTICAL VALIDATION OF THE NEXT-GENERATION T-TAS wS SYSTEM	7
B-247 BLADE-R: streamlined RNA extraction for clinical diagnostics and high-throughput applications	7
Do You See What I See? Automated IFE Interpretation Using Machine Learning	7
Age-Specific Control and Alzheimer Disease Reference Curves and z -Scores for Glial Fibrillary Acidic Protein in Blood	7
A-400 11 month study of thrice daily testing of blood samples on dual GEM 5000s demonstrates 24 hour new cartridge instability	7
A-378 Acceptance and Harmonization of i-STAT Cartridges. A Practical Example with G3+ cartridges	7
A-410 A laser scanning smartphone-based imaging platform toward point-of-care diagnostic testing	7
B-292 Performance of fentanyl immunoassays in a pediatric patient population	7
Next-Level Natriuretic Peptide Measurement	7
Personalized and Population-Based Reference Intervals for 48 Common Clinical Chemistry and Hematology Measurands: A Comparative Study	6
Clinical Metagenomics—from Proof-of-Concept to Routine Use	6
Commentary on Severe Hypophosphatemia: The Hidden Truth	6
The Pivotal Role of Whole Genome and Transcriptome Sequencing in a Rare Case of Systemic Mastocytosis with Associated Myelodysplastic/Myeloproliferative Neoplasm with Neutrophilia	6
Is Hemodialysis So Efficient in Removing Phosphate?	6
The Next Generation of Population-Based DFNB16 Carrier Screening and Diagnosis: STRC Copy-Number Variant Analysis from Genome Sequencing Data	6
Evaluation of Sperm DNA Integrity by Mean Number of Sperm DNA Breaks Rather Than Sperm DNA Fragmentation Index	6
Reference Interval Harmonization: Will Big Data Provide a Solution?	6
Interpreting EQA—Understanding Why Commutability of Materials Matters	6
Extent of Equivalence of Results for Urine Albumin among 3 Candidate Mass Spectrometry Reference Measurement Procedures	6
Polygenic Risk Scores: Genomes to Risk Prediction	6
Government Mandates Immediate Access to Cancer Test Results: Patient Empowerment or Secondary Harm?	6
Pediatric Vaccine-Induced Antibody Thresholds: Rethinking Pre-Immunosuppression Serologic Testing and Revaccination Implications	6
Interlaboratory Comparison of Antibody-Free LC-MS/MS Measurements of C-peptide and Insulin	6
Transitioning Alzheimer Disease Blood Biomarkers into Primary Care: Are We There Yet?	6
Placental Biomarker Testing for Evaluation of Suspected Preeclampsia	6
Autoverified Chocolate-Colored Plasma Samples	6
Commentary on Positive Syphilis Serologies after Intravenous Immunoglobulin Treatment: A Diagnostic Confusion That Needs Emphasis	6
Commentary on Negative Sweat Chloride Testing in the Setting of a Positive Newborn Screen and CFTR Compound Heterozygosity	6
A-153 Study of the evaluation of fragment flag and percentage schistocyte count in MINDRAY® BC-6800 PLUS in a public pediatric hospital in Argentina	6
Determinants of Cardiac Myosin Binding Protein C in the General Population	6
B-336 Comparison of the LZI Fentanyl Enzyme Immunoassay With ARKII and SEFRIA Fentanyl Assays on Beckman AU Analyzer	5
Next-Generation Methods for More Precise Measurement of Cancer Genetic Changes	5
B-340 Evaluation of the Analytical Performance of Three Major Immunoglobulins Assays on the Atellica CI Analyzer	5
B-081 Analytical comparison of a novel, fully automated multiplexed microarray immunoassay and routine methods for the detection of IgA antibodies to tissue transglutaminase in a laboratory in England	5
A-380 Maverick: Revolutionizing Immunoassay Testing with Photonic Ring Resonance Technology for Faster, More Accurate Results	5
A-306 Standardization of Automated Methodology for Qualitative Molecular Detection of HIV-1 in Dried Blood Spots (DBS)	5
B-184 Development and Validation of a High-performance Liquid Chromatography-Mass Spectrometry Method for Analyzing Phenolic Acids Metabolites in Feces	5
A-262 Analytical and Clinical Validation of a Multiplex RT-PCR based Mpox Assay	5
B-165 The EXENT System reliably distinguishes daratumumab from endogenous monoclonal immunoglobulins in multiple myeloma patients	5
A-361 Long-term analytical variation of placental growth factor (PlGF) and soluble fms-like tyrosine kinase-1 (sFlt-1) for preeclampsia risk assessment: a 5-year review	5
B-115 Development of Anti-14-3-3eta Multiplex Laboratory Developed Test (LDT) to aid in the Diagnosis of Axial Spondyloarthritis (axSpA)	5
A-088 Establish Laboratory Limit of Blank and Limit of Detection for LH Assay on the Ortho VITROS 3600 System	5
A-362 Hemolysis Detection and Flagging of Potassium Results on GEM Premier 7000 with iQM3	5
B-303 Comparison of Tacrolimus Concentrations Obtained By the Newly Approved Alinity i Tacrolimus Assay With a Reference Liquid-Chromatography Combined With Tandem Mass spectrometry Assay	5
B-161 Liquid chromatography/mass spectrometry analysis of ethyl glucuronide and ethyl sulfate using a perfluorophenyl stationary phase	5
A-358 Comparison of Immunoregulatory miRNA, Human Milk oligosaccharides (HMO’s) and Gut Microbiomes between Infants Fed with Human Breast Milk Versus Infant Formula	5
A-251 Comparison of Antimicrobial Susceptibility Profiles of Enterobacteriaceae spp. Isolates from Retail Meat Products Imported from USA and Brazil or Domestically Produced on Caribbean Island	5
A-327 Pre-analytical and Analytical Modifications to Improve the Quality of Pediatric Lead Tests	5